Bioline Rx Ltd ADR (BLRX): Next-Year EPS Estimate 31.18%
As of 2026-06-04, Bioline Rx Ltd ADR (BLRX) has a next-year EPS growth estimate of 31.18%.
On 2026-06-02, analyst consensus for BLRX's next-year EPS growth shifted from 38.53% to 31.18% — a negative change of 7.35 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 31.18%
- EPS growth this year
- N/A
- EPS next quarter (est)
- -$0.15
- Last price
- $3.36
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 31.18% | N/A | -$0.15 | $3.36 |
| 2026-06-03 | 31.18% | N/A | -$0.15 | $3.28 |
| 2026-06-02 | 31.18% | N/A | -$0.15 | $3.39 |
| 2026-06-01 | 38.53% | N/A | -$0.16 | $3.48 |
| 2026-05-31 | 38.53% | N/A | -$0.16 | $3.78 |
| 2026-05-28 | 39.09% | N/A | -$0.32 | $3.59 |
| 2026-05-27 | 39.09% | N/A | -$0.32 | $3.37 |
| 2026-05-26 | 39.09% | N/A | -$1.04 | $3.16 |
| 2026-05-25 | 39.09% | N/A | -$1.04 | $3.06 |
| 2026-05-24 | 39.09% | N/A | -$1.04 | $3.06 |
| 2026-05-21 | 39.09% | N/A | -$1.04 | $2.86 |
| 2026-05-20 | 39.09% | N/A | -$1.04 | $2.75 |
| 2026-05-19 | 39.09% | N/A | -$1.04 | $2.63 |
| 2026-05-18 | 39.09% | N/A | -$1.04 | $2.80 |
| 2026-05-17 | 39.09% | N/A | -$1.04 | $2.98 |
| 2026-05-14 | 39.09% | N/A | -$1.04 | $3.06 |
| 2026-05-13 | 39.09% | N/A | -$1.04 | $3.10 |
| 2026-05-12 | 39.09% | N/A | -$1.04 | $3.11 |
| 2026-05-11 | 39.09% | N/A | -$1.04 | $2.98 |
| 2026-05-10 | 39.09% | N/A | -$1.04 | $3.07 |
| 2026-05-07 | 39.09% | N/A | -$1.04 | $3.10 |
| 2026-05-06 | 39.09% | N/A | -$1.04 | $3.35 |
| 2026-05-05 | 39.09% | N/A | -$1.04 | $3.04 |
| 2026-05-04 | 39.09% | N/A | -$1.04 | $3.04 |
| 2026-05-03 | 39.09% | N/A | -$1.04 | $2.86 |
| 2026-04-30 | 39.09% | N/A | -$1.04 | $2.75 |
| 2026-04-29 | 39.09% | N/A | -$1.04 | $3.07 |
| 2026-04-28 | 39.09% | N/A | -$1.04 | $2.63 |
| 2026-04-27 | 39.09% | N/A | -$1.04 | $2.23 |
| 2026-04-26 | 39.09% | N/A | -$1.04 | $2.27 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Bioline Rx Ltd ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Bioline Rx Ltd ADR (BLRX) has a next-year EPS growth estimate of 31.18%, based on analyst consensus.
When was the latest EPS estimate revision for BLRX?▾
The most recent revision occurred on 2026-06-02, when analysts adjusted the next-year EPS growth estimate from 38.53% to 31.18%.
What sector and industry does Bioline Rx Ltd ADR belong to?▾
Bioline Rx Ltd ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BLRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Bioline Rx Ltd ADR (BLRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports